POSITIVE COATING
PVD and ALD Technologies for Medical Device Coatings
A study by Mayo clinic has found that the prostate-specific antigen (PSA) test could be a vital tool in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer.
A study by Mayo clinic has found that the prostate-specific antigen (PSA) test could be a vital tool in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer.
The study reported that men in their 40s and 50s with a baseline PSA at or above the median PSA are more likely to undergo a biopsy and be diagnosed with low-risk prostate cancer.
The PSA test measures the amount of PSA, a protein produced by cells of the prostate gland, in the patient’s blood. It allows physicians to determine a patient’s potential risk of developing prostate cancer.
High PSA levels may occur due to benign prostate enlargement or inflammation of the urinary tract.
PVD and ALD Technologies for Medical Device Coatings
Components for Medical Devices
PI Ceramic - Piezoelectric Components for Medical Device Applications